In The News

Toronto's Centre for Addiction and Mental Health (CAMH) has been selected to test the updated diagnostic criteria for the American Psychiatric Association's (APA) fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM) -- the manual used by medical professionals around the world. CAMH is currently one of only seven adult field trial sites in North America and the only Canadian organization selected to test the manual. As reported by The Medical News, the selection process was competitive, out of 65 organizations that submitted proposals only 11 participants were chosen.  

"We are honoured to be selected as one of the field trial sites," said Dr. Michael Bagby, Director of Clinical Research at CAMH. "Our role in the development of DSM-5 is a reflection of CAMH's standing in medical research, particularly in the field of psychiatry and mental disorders." APA has reported that the selection process was very competitive; only 11 organizations were chosen from the 65 that submitted proposals to be considered for a field trial site, and CAMH was the only Canadian site chosen."


"The field trials held at CAMH will be led by Drs. Bruce Pollock, Michael Bagby and Kwame McKenzie. Disorders being studied at CAMH include schizophrenia, schizoaffective disorder, attenuated psychotic symptoms syndrome, and personality disorders. Clinicians participating in the field trial will evaluate new and existing patients at different stages of treatment using the proposed DSM-5 diagnostic criteria and measures."

read full story here
original source The Medical News